SCHEMBL23964347

SCHEMBL23964347

c1ccc2nc(N3CCN(Cc4cc5ccccc5[nH]4)CC3)ccc2c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 2/20 0.60
HRH3 Q9Y5N1 5/20 0.58
HTR1A P08908 4/20 0.53
DRD2 P14416 4/20 0.53
DRD3 P35462 4/20 0.53
DRD4 P21917 3/20 0.53
ADRA2A P08913 1/20 0.53
ADRA2B P18089 1/20 0.53
ADRA2C P18825 1/20 0.53
OPRK1 P41145 1/20 0.53
HTR3E A5X5Y0 2/20 0.51
KDM4E B2RXH2 2/20 0.51
HTR3B O95264 2/20 0.51
ALDH1A1 P00352 2/20 0.51
CYP1A2 P05177 2/20 0.51
HTR3A P46098 2/20 0.51
HTR3D Q70Z44 2/20 0.51
HTR3C Q8WXA8 2/20 0.51
USP2 O75604 1/20 0.51
ADRB1 P08588 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6786631 0.81 DRD4 (0.77) HRH4HTR1ADRD2DRD3DRD4
SCHEMBL30041333 0.81 DRD4 (0.77) HRH4HTR1ADRD2DRD3DRD4
SCHEMBL30041328 0.79 HRH4 (0.69) HRH4HRH3HTR1ADRD2DRD3
SCHEMBL8682915 0.79 HRH4 (0.69) HRH4HRH3HTR1ADRD2DRD3
SCHEMBL25184143 0.78 HRH4 (0.64) HRH4HRH3HTR1ADRD2DRD3
SCHEMBL23964222 0.78 DRD4 (0.60) HRH4HRH3HTR1ADRD2DRD3
SCHEMBL6231596 0.77 HRH3 (0.68) HRH4HRH3HTR1ADRD4HTR3E
SCHEMBL23964200 0.77 HRH4 (0.63) HRH4HRH3HTR1ADRD2DRD3
SCHEMBL30041451 0.77 HRH4 (0.63) HRH4HRH3HTR1ADRD2DRD3
SCHEMBL8631184 0.77 HRH3 (0.56) HRH4HRH3HTR1AHTR3EKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230150980-A1 COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF ANIMA BIOTECH INC. (US) 2023-05-18 US disclosed
US-20230150980-A1 COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF ANIMA BIOTECH INC. (US) 2023-05-18 US disclosed
CN-115427404-A Collagen 1 translation inhibitors and methods of use thereof 艾尼莫生物科技公司 2022-12-02 CN disclosed
WO-2021216665-A9 COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF ANIMA BIOTECH INC. (US) 2021-12-02 WO disclosed
WO-2021216665-A1 COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF ANIMA BIOTECH INC. (US) 2021-10-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150980-A1 COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF COL1A1, COL2A1, COL14A1 HRH4 4471/4885HRH3 4170/4885HTR1A 2592/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.